SMITH DAVID V (Executive Vice President & CFO) reported 1 transaction at FIVE PRIME THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/26/2021ACC: 0001209191-21-014641
Officer· Executive Vice President & CFO
Since Nov 2018
-5.11K
Net shares
Net seller
$131.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.11K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.11K
Price / share
$25.71
Trade value
$131.38K
% of position
6.5%
2/24/2021
78.06K→72.95K
Total
Net shares
−5.11K
Net value
-$131.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2021 | F · Tax Withholding | −5.11K | $25.71 | $131.38K | 6.5% | 78.06K | 72.95K |
| Total | −5.11K | -$131.38K | ||||||
Derivative Transactions0
No derivative transactions reported